Mr. Ainsworth brings over two decades of industry and market access experience to Tonix U.S. Food and Drug Administration ...
Tonix Pharmaceuticals (NASDAQ: TNXP) , a biopharmaceutical company focused on marketed products and development candidates, announced its participat ...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products ...
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) fell 8.4% on Wednesday . The stock traded as low as $0.32 and last traded at $0.33. 80,811,016 shares traded hands during trading, ...
Shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) dropped 7.8% during mid-day trading on Tuesday . The company traded as low as $0.33 and last traded at $0.33.
StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a report published on Wednesday. The brokerage issued a hold rating on the stock. Tonix Pharmaceuticals ...
StockNews.com began coverage on shares of ENGlobal (NASDAQ:ENG – Free Report) in a research report sent to investors on Wednesday. The firm issued a sell rating on the construction company’s stock.
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report)’s stock price traded down 5.3% on Monday . The stock traded as low as $0.31 and last traded at $0.32. 28,828,476 shares changed ...
Shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) were down 8.7% during trading on Friday . The company traded as low as $0.31 and last traded at $0.34. Approximately ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Nasdaq is expected to announce changes to the Nasdaq-100 Index on Friday, which could be about more than just prestige for the companies that earn entry. The reconstitution can be an important ...
Tonix Pharmaceuticals Holding Corp. recently revealed in an 8-K filing with the U.S. Securities and Exchange Commission that the U.S. Food and Drug Administration (FDA) has set a Prescription Drug ...